Actionnariat et activité des initiés pour Connect Biopharma Holdings Limited (CNTB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.24 |
| Capitalisation | $78M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-30 | Xanthopoulos Kleanthis Gabriel | A-Award | 3,738 | |
| 2026-06-30 | LIU JEAN I | A-Award | 6,718 | |
| 2026-05-29 | Huang James | P-Purchase | 150,000 | $372K |
| 2026-03-31 | Xanthopoulos Kleanthis Gabriel | A-Award | 2,816 | |
| 2026-03-31 | LIU JEAN I | A-Award | 5,061 | |
| 2026-03-31 | Huang James | P-Purchase | 1,160,000 | $4.0M |
| 2026-03-18 | Huang James | |||
| 2026-03-16 | Szekeres David Leslie | |||
| 2026-03-16 | Szekeres David Leslie | 1,772,489 | $3.1M | |
| 2026-03-16 | Szekeres David Leslie | 409,355 | $397K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $61.3M | $6.4M | $23.7M | $267.7M | $79.0M | $105.7M | $78.2M | $38.3M |
| Placements à Court Terme | $371012 | $635147 | $306412 | 0 | $73.4M | $12.6M | $15.5M | $6.0M |
| Créances | 0 | $25109 | $40587 | $7.4M | $232000 | $351000 | $1.1M | $161000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $68.1M | $7.5M | $24.8M | $275.1M | $155.8M | $122.6M | $97.0M | $50.9M |
| Immobilisations Corporelles | $479612 | $70954 | $184485 | $9.4M | $5.4M | $4.7M | $4.2M | $4.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | $8019 | $3.5M | $3.2M | $62000 | $53000 | $45000 |
| Actifs Totaux | $69.3M | $7.7M | $25.4M | $291.1M | $174.0M | $127.4M | $101.3M | $56.1M |
| Dettes Fournisseurs | $499672 | $472504 | $577701 | $12.7M | $11.9M | $2.2M | $342000 | $2.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $966556 | $568070 | $890937 | $18.0M | $15.6M | $25.3M | $8.5M | $13.6M |
| Dette à Long Terme | $87.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $88.7M | $13.9M | $49.5M | $18.8M | $16.5M | $25.9M | $9.1M | $14.1M |
| Réserves | -$18.9M | -$6.1M | -$25.1M | -$361.8M | -$479.8M | -$329.7M | -$345.4M | -$400.8M |
| Capitaux Propres | -$19.4M | -$6.2M | -$24.0M | $272.3M | $157.5M | $101.5M | $92.2M | $42.0M |
| Dette Totale | $87.7M | $18287 | $21407 | $125000 | $431000 | $465000 | $178000 | $690000 |
| Dette Nette | $21.8M | -$7.0M | -$24.0M | -$267.6M | -$152.0M | -$117.8M | -$93.5M | -$43.7M |
| Fonds de Roulement | $67.1M | $7.0M | $23.9M | $257.1M | $140.2M | $97.3M | $88.5M | $37.3M |
Santé financière
| Dette / Capitaux propres | 0.02 |
| Ratio de liquidité | 3.74 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -5.94 |
Rentabilité
| Rentabilité des capitaux propres | -132.16% |
| Rentabilité du capital investi | -135.74% |
| Rentabilité des actifs | -98.94% |
| Marge brute | 100.00% |
| Marge opérationnelle | -90740.62% |
| Marge nette | -86687.50% |
Entreprises liées: ARTV · CNTX · IFRX · IMA · KLRS · MGX · OVID
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CNTB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions